216.56MMarket Cap
LossP/E TTM
Avidity Biosciences Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Avidity Biosciences Inc is 8.73, ranking 70 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -4.38, which is -62.85% below the recent high of -1.63 and -349.26% above the recent low of -19.66.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.